Skip to Content


In the US, Nelfinavir (nelfinavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Treatment of HIV infection

HIV protease inhibitor

Chemical Name

3-Isoquinolinecarboxamide, N-(1,1-dimetyletyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-metylbenzoyl)amino]-4-(phenyltio)butyl]-, [3S-[2(2S*,3S*),3α,4aβ,8aβ]]-

Foreign Names

  • Nelfinavirum (Latin)
  • Nelfinavir (German)
  • Nelfinavir (French)
  • Nelfinavir (Spanish)

Generic Names

Brand Names

  • Emnel
    Emcure, India
  • Nelfin
    Hetero, India
  • Avifix
    Beximco, Bangladesh
  • Nelvir
    Square, Bangladesh
  • Nemacina
    LKM, Argentina
  • Viracept
    Japan Tobacco, Japan; Pfizer, Canada; Roche, Italy; Roche, Portugal; ViiV Healthcare, United States
    Roche, Germany


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.